ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Zura Bio Ltd
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$3.81−0.07 (-1.80%)
Close on Oct 19, 2026
- Market cap
- $483.12M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.60 (+18.69%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $483.12M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -13.44%
Fundamentals
- Net income
- -$85.74M
- EPS, diluted
- -$1.12
- Free cash flow
- -$64.94M
- Diluted shares
- 127M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Operating income
-$92.75M
Net income
-$85.74M
EPS, diluted
-$1.12
Free cash flow
-$64.94M
Reported periodTrailing twelve months